This piece is written in a question-and-answer format covering the kinds of questions an endocrinologist commonly fields about GLP-1 medications, based on established clinical guidance and published research rather than an actual interview transcript.
How do these drugs actually work in the body?
GLP-1 receptor agonists mimic a natural gut hormone that slows digestion, increases insulin release in response to food, and signals satiety to the brain. Tirzepatide adds a second mechanism through the GIP receptor. Both approaches work with the body's existing hormonal feedback systems rather than overriding them entirely.
Is weight regain common after stopping?
Published follow-up data, including extension studies from the STEP trial program, has documented that a meaningful portion of lost weight tends to return after discontinuation, which clinicians generally frame as evidence that these medications are treating a chronic condition requiring ongoing management, similar to how blood pressure medication is typically approached, rather than a short-term fix.
How is candidacy for these drugs actually determined?
Approved use is based on specific criteria, generally a BMI threshold or a lower BMI threshold combined with a weight-related health condition for weight management use, or a type 2 diabetes diagnosis for that indication, evaluated alongside a patient's full medical history and any contraindications discussed in this site's safety guides.
What do you want patients to understand about compounded versions?
The clinical concern centers on the manufacturing and quality assurance gap discussed throughout this site's compounding coverage, not necessarily the underlying chemistry, since a properly compounded product using verified active ingredient can be clinically reasonable, but verifying that quality is harder for a patient to do than simply trusting a familiar brand-name product's regulatory oversight.
What's the most overlooked part of using these medications well?
Clinicians frequently emphasize that the medication works best as part of a broader approach including nutrition and physical activity support, not as a replacement for that support, and that the gradual dose-escalation schedule exists specifically to manage tolerability, skipping it to reach a higher dose faster generally increases side effect risk without improving outcomes.
The Bottom Line
These questions reflect the kind of practical, clinically grounded guidance a specialist would typically walk a patient through, beyond just the trial statistics covered in this site's research section, and underscore why an actual consultation, not just background reading, remains an important part of using these medications well.
A Final Question: What Should Patients Ask at Their First Visit?
Bringing a full medication and supplement list, being honest about past attempts at weight management and what has or hasn't worked, and asking directly about the specific dose-escalation schedule and what side effects to expect at each step are all concrete, practical questions that help a first consultation actually accomplish what it's meant to, rather than functioning as a quick formality on the way to a prescription.